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Abstract
Aldosterone is the key regulating hormone of whole-body fluid and electrolyte 
homeostasis. Perturbations in aldosterone synthesis and over-activation of the 
mineralocorticoid receptor (MR) can lead to excess salt reabsorption and hyperten-
sion. The cortical collecting duct (CCD) is the main site of action in the kidney 
for aldosterone regulation of whole-body sodium homeostasis through actions 
on the epithelial sodium channel (ENaC) and the Na/K-ATPase (Na/K pump). 
Aldosterone stimulates ENaC trafficking into the apical cell membranes in the CCD 
and enhances channel stability and open probability, as well as activating the baso-
lateral membrane Na/K pump to produce an overall increase in the transepithelial 
reabsorption of sodium. Aldosterone/MR regulates the activity of ENaC in the CCD 
through both rapid non-genomic (secs-mins) and latent genomic (hours-days) sig-
naling pathways. These rapid and slow responses of renal Na+ transport pathways 
to aldosterone are often treated as distinct and separate events. However, recent 
evidence points to a close integration between genomic and non-genomic responses 
to aldosterone to regulate ENaC and Na/K pump activity via protein kinase signal-
ing pathways. Here, we review the integration of aldosterone membrane-initiated 
non-genomic and nuclear genomic regulations of renal sodium transport via 
protein kinase signaling pathways and in particular via protein kinase D isoforms.
Keywords: aldosterone, non-genomic, protein kinase D, ENaC, Na/K pump, 
renal Na+ transport
1. Introduction
The distal nephron of the kidney is the principal site for salt conservation in the 
body, and the dysregulation of Na+ homeostasis can contribute significantly to the 
development of hypertension [1]. Aldosterone is the major salt conservation hormone, 
and increased circulating levels of the hormone in low Na+ diet, salt-wasting, or 
hypovolemia such as in hemorrhage produce increased sodium reabsorption in target 
epithelial tissues of the kidney, distal colon, and sweat gland to restore whole-body salt 
homeostasis and extracellular fluid volume. The kidney and cardiovascular systems are 
the principal organs for aldosterone action to regulate blood pressure. Rapid non-
genomic and latent genomic actions of aldosterone on both renal and cardiac functions 
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have been described. The main ion transport targets for the natriferic actions of aldo-
sterone in the kidney are the epithelial sodium channel ENaC and the Na/K-ATPase 
pump. Aldosterone can also affect other epithelial ion transport systems such as 
potassium and hydrogen ion secretion by activating the ROMK K+ channel and the H+-
ATPase pump, respectively [2]. Aldosterone regulates sodium transport in the kidney 
through its actions on ENaC activity in the distal nephron principal cells of the cortical 
collecting duct (CCD) as well as activating the basolateral membrane Na/K pump, to 
produce an overall increase in the transepithelial uptake of sodium. Aldosterone also 
stimulates K+ recycling at the basolateral membrane through activation of inwardly 
rectifying KATP channels which serves to maintain a favorable cell membrane hyper-
polarization for sustained Na+ influx via ENaC, in addition to matching K+ recycling 
rate with Na/K-ATPase pump activity to preserve epithelial cross talk (maintaining 
equilibrium between apical and basolateral ionic permeabilities) [3].
Aldosterone acts on ENaC via its receptor MR to produce rapid (non-genomic) 
effects on intermediate cell signaling molecules (protein kinases, MAP kinases, SGK, 
Ca2+, pH, etc.) to enhance ENaC membrane trafficking, channel activity, and stabil-
ity followed by a latent (genomic) phase to increase the expression of ENaC channel 
subunits and further stabilization of active channels in the apical membrane [4]. 
For the past 25 years, it was thought that aldosterone and its receptor MR modulated 
renal sodium reabsorption principally by preventing the membrane retrieval and 
degradation of ENaC in the cortical collecting duct via serum glucocorticoid kinase 
(SGK) [5]. However mouse models deficient in or over-expressing SGK did not show 
alterations in blood pressure or renal Na+ excretion, pointing to SGK redundancy or 
other regulatory ENaC pathways more potent than SGK [6]. A novel aldosterone sig-
naling pathway acting through protein kinase D isoforms (PKD) was discovered over 
a decade ago [7] which is pivotal in transducing aldosterone/MR regulation of ENaC 
subcellular trafficking and channel activity in CCD, both by rapid non-genomic and 
latent genomic signaling mechanisms [2, 4]. The role of rapid aldosterone/MR signal-
ing responses in modulating renal sodium reabsorption and whole-body electrolyte 
balance is still poorly understood; however, recent observations demonstrate that 
PKD1 activation by aldosterone rapidly regulates ENaC trafficking, one of the earliest 
physiological responses to the hormone [8]. This review focuses on non-genomic 
aldosterone regulation of ENaC and renal sodium transport by protein kinase signal-
ing pathways and the impact of rapid kinase signaling, in particular protein kinase D, 
on the latent genomic responses to influence renal sodium reabsorption in the CCD.
1.1 Non-genomic actions of aldosterone on ion transporters
Aldosterone tightly regulates epithelial ion transport in the renal CCD by both 
genomic and non-genomic processes (Figure 1). Aldosterone diffuses across the 
basolateral membrane of the CCD cell and binds to MR in the cytosol inducing 
receptor dimerization and the translocation to the nucleus. The hormone-receptor 
complex can bind to GRE response elements and subsequently recruit other tran-
scription factors. During genomic regulation of ion transport, the aldosterone/MR 
complex acts as a ligand-dependent transcription factor that can induce the expres-
sion of several genes including ENaC, Na+/K+-ATPase, ROMK, and SGK [9–11]. 
The binding of aldosterone to MR in the cytosol can also stimulate protein kinase 
signaling pathways. The rapid activation of certain protein kinases such as MAPK 
and PKD occurs through the transactivation of EGFR [12, 13].
Rapid activation of signal transduction cascades is amplified via aldosterone-
stimulated non-transcriptional responses. Current available evidence indicates 
that aldosterone non-genomic responses in CCD are dependent on the interaction 
of aldosterone with cytosolic MR and not via a nonclassical membrane-bound 
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aldosterone receptor [14]. The signaling cascades which are rapidly activated 
through the interaction of MR and aldosterone can be inhibited by MR-specific 
antagonists, for example, spironolactone or eplerenone [15, 16]. There is also 
strong evidence that, under certain conditions, aldosterone/MR can transactivate 
other receptors such as the epithelial growth factor receptor EGFR and G-protein 
estrogen receptor GPER [12, 13, 17].
Non-genomic renal responses to aldosterone have long been described in various 
experimental animal and cell models. A primary focus of non-genomic aldosterone 
research has been the rapid actions of aldosterone on the reabsorption of sodium in 
the distal nephron, in particular rapid regulation of Na+ uptake through ENaC and 
basolateral extrusion of Na+ via the Na/K pump [2, 4, 29, 30]. The active sodium 
transport target for aldosterone was first demonstrated in amphibian urinary bladder 
[31]. One of the earliest reports of rapid actions of aldosterone on sodium trans-
port in the kidney was in 1957 when Cole described the rapid effect of aldosterone 
administration for 30 min to cause a reduction in urinary loss of Na+ and increased 
reabsorption by the renal tubules in response to intravenously administered saline 
in adult male rats [18]. It has also been documented that aldosterone infusion into 
aldosterone-suppressed rats (by adrenalectomy or infusion with sodium bicarbonate) 
resulted in the rapid increase in urinary Na+ excretion [19]. The rapid non-genomic 
actions of aldosterone in vivo were further demonstrated in the intact rat when 
aldosterone induced a rapid increase in urinary Na+ excretion within 15 min [20].
Figure 1. 
Genomic and non-genomic actions of aldosterone on epithelial ion transport. In both pathways, aldosterone 
enters the cytoplasm to bind with MR. A rapid non-genomic signaling pathway is initiated within secs-mins 
(green arrows) which transactivates the EGFR receptor to produce phosphorylation activation of protein 
kinases such as MAPK and PKD. Aldosterone may also interact with other receptors such as GPER or directly 
with specific kinases (PKC and PKA) to modulate intracellular Ca2+ or pH. The non-genomic effects of 
aldosterone result in rapid activation of various ion transporters (ENaC, Na/K pump, Na/H exchanger, 
K+ channels, and H+-ATPase pumps). Genomic responses occur on a longer time scale of hours-days (red 
arrows) and are the result of aldosterone/MR translocation to the nucleus, interaction with DNA steroid 
response elements, mRNA activation/inhibition, and the delayed expression or degradation of ion transporter 
proteins. Cross talk exists between genomic and non-genomic pathways in both directions. The rapid activation 
of protein kinases primes the epithelial cells for the latent genomic response by enhancing the trafficking 
and membrane localization of ion transporters. In addition, non-genomic MAPK and ERK1/2 signaling 
can activate transcription factors such as CREB which facilitates nuclear translocation of MR and gene 
transcription to cause expression of protein kinase signaling intermediates [2, 4].
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Aldosterone has been shown to regulate epithelial K+ channels involved in tran-
sepithelial K+ secretion and K+ recycling. In the frog skin epithelium which shares 
similar functional properties to CCD, aldosterone rapidly activated ATP-sensitive 
K+ (KATP) channels which generate the favorable electrical driving force for apical 
Na+ entry via ENaC, through an increase in the open probability of KATP channels 
within 15 min of stimulation by hormone [21]. The stimulatory effect of aldoste-
rone on KATP channels was caused by activation of a Na
+/H+ exchanger shifting 
intracellular pH to more alkaline values at which the KATP channel open probability 
was highest [22]. The non-genomic effects of aldosterone on KATP channels and Na
+/
H+ exchanger were very rapid in the frog skin epithelium and renal A6 CCD cells 
(within 10 min) [23].
The regulation of intracellular pH in epithelia such as the renal CCD occurs via 
the Na+/H+ exchanger family (NHE) which is responsible for the exchange of intra-
cellular H+ for extracellular Na+. NHE, specifically the NHE1 isoform, is expressed 
in the basolateral membrane in polarized epithelial cells where it plays a role in the 
regulation of cell volume and cytoplasmic pH. Aldosterone rapidly activates NHE 
isoforms by non-genomic signaling to promote alkalinization of the cytoplasm 
within 20 min in the kidney of amphibians [24]. In MDCK cells, the aldosterone-
dependent increase in pHi is linked to the activation of NHE [25]. The rise in pHi is 
also dependent on the activation of ERK1/2 along with the rapid increase in [Ca2+ i] 
that occurs within 1 min of treatment with aldosterone [26]. Other studies using 
M1-CCD cells showed that aldosterone induced a NHE-dependent increase in the 
recovery of pHi from an acid load within 5 min of hormone treatment. The rapid 
pH recovery response to aldosterone was reduced by PKCα inhibition or by the 
activation of MAPK [27]. NHE also has a role in regulating cell volume as well as the 
induction of proliferation and cell growth. In fact, one of the first pieces of evidence 
for non-genomic actions of aldosterone on the Na+/H+ exchanger was reported for 
cell volume regulation in leukocytes [28].
Another ion transporter target of non-genomic aldosterone signaling in the 
CCD is the V-type H+ pump (H+-ATPase) which is expressed in intercalated cells 
of the CCD and is the major mechanism for aldosterone-regulated acid secretion 
in the kidney. Aldosterone enhances urinary acidification by stimulating H+ efflux 
via the H+-ATPase pump. This response was first described in turtle bladder [32]. 
It was later shown in whole-cell patch clamp recordings of mitochondria-rich cells 
of the frog skin that aldosterone treatment resulted in the rapid exocytotic inser-
tion of H+-ATPase pumps into the luminal membrane within 10 min of hormone 
stimulation [33]. The rapid insertion of H+ pumps into the membrane was sensitive 
to PKC inhibition and disruption of the cytoskeleton. In the kidney, the reabsorp-
tion of bicarbonate coupled with the release of H+ into the renal ultrafiltrate in the 
distal nephron accounts for acid-base regulation. Aldosterone has a crucial role 
in regulating the renal H+-ATPase through non-genomic signaling responses. For 
example, stimulation with aldosterone for 15 min resulted in the MR-dependent 
increase in the excretion of H+ from acidic type A intercalated cells of the outer 
medullary collecting ducts of mice [34]. These responses in the kidney were similar 
to that observed in the frog skin whereby the increase in H+ pump activity was 
dependent on the Ca2+-induced activity of PKC [33]. Moreover, mice injected with 
aldosterone displayed an increase in the expression of H+-ATPase in the apical 
membrane of type A intercalated cells [34] further strengthening the evidence for 
aldosterone in regulating the trafficking of H+-ATPase pumps in the maintenance 
of acid-base homeostasis.
In the renal CCD, K+ enters the principal cells through the Na+/K+-ATPase in the 
basolateral membrane and is then secreted into the lumen via K+ channels along 
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the apical membrane [35]. The main K+ secreting channel in the kidney is ROMK 
which is expressed in the apical membrane of cells in the ASDN [36]. The func-
tion of ROMK is regulated by aldosterone through SGK1 activity which was found 
to regulate cell surface expression of the channel [37]. K+ can also enter the cell 
through K+ channels located in the basolateral membrane of the CCD [38] which 
may occur due to the stimulation of Na+/K+-ATPase by mineralocorticoids [39]. 
ATP-dependent K+ channel (KATP) activity in A6 CCD renal cells was rapidly stimu-
lated by aldosterone (15 min), and this activation modulated the open probability 
of the channel [21]. Aldosterone has also been shown to produce a non-genomic 
inhibition of Ca2+-dependent intermediate conductance channels (IKCa) located in 
the basolateral membrane of colonic crypt cells, and this effect was PKC-dependent 
[40, 41]. Additionally, aldosterone can also activate Na+/H+ exchange through Ca2+- 
and PKC-dependent signaling pathways that results in an upregulation of KATP and 
an inhibition of IKCa channels [42]. Taken together, it is evident that aldosterone 
can induce rapid signaling responses that impact upon several membrane ion 
transporter targets by modulating intrinsic biophysical and electrophysiological 
properties of ion channels, pumps, and exchangers.
1.2 Non-genomic actions of aldosterone on protein kinase signaling pathways
Non-genomic effects of aldosterone produce rapid phosphorylation of a wide 
range of protein kinases such as extracellular stimulus-regulated kinase (ERK) 1/2, 
protein kinase C (PKC isoforms), cAMP-dependent protein kinase A (PKA), and 
protein kinase D isoforms (PKD) (Figure 2) [2, 4, 29, 42–47]. It is vital to under-
stand how aldosterone stimulation of these signaling cascades augments the activity 
of sodium ion transporters ENaC and Na+/K+-ATPase pump in order to establish the 
physiological relevance of non-genomic signaling for transepithelial Na+ reabsorp-
tion processes that are instigated in advance of transcriptional control. For the past 
25 years, it was thought that aldosterone and the mineralocorticoid receptor modu-
lated renal sodium reabsorption principally by activating the epithelial Na+ channel 
ENaC in the cortical collecting duct via serum glucocorticoid kinase (SGK) [5]. 
However, mouse models deficient in or over-expressing SGK do not show altera-
tions in blood pressure or renal Na+ excretion [6], pointing to redundancy or other 
regulatory ENaC pathways more potent than SGK.
Aldosterone has been shown to exert rapid non-genomic effects on the activa-
tion of several kinase families including PKC, PKD, ERK1/2, and MAPK through 
the transactivation of EGFR via the non-receptor tyrosine kinase c-Src [2, 4]. The 
most widely documented mechanism underlying the rapid responses to aldosterone 
is the activation of protein kinase signaling cascades. Several research groups have 
investigated the role of ERK1/2 activation in aldosterone-sensitive models such 
as Madin-Darby canine kidney (MDCK) cells [25], M1-CCD cells [27], vascular 
smooth muscle cells (VSMC) [48], cardiac myocytes [49], and the mesangial cells 
of the glomerulus [50]. The activation of ERK1/2 is linked to the variation of cell 
growth which can occur through hypertrophy [49] or by promoting proliferation 
[51]. The activation of ERK1/2 is modulated by the simultaneous activation of 
other signaling cascades. In MDCK cells, the activation of ERK1/2 occurs within 
5 min and can be sustained over a period of hours (96). However, in M1-CCD cells, 
ERK1/2 activation is linked to the transactivation of EGFR and subsequent activa-
tion of PKD1 which has been shown to be necessary to maintain the cyclical activa-
tion of ERK1/2 beyond 5 min [25]. Additionally, PKD1 involvement in stabilizing 
ERK1/2 activation occurs in response to growth factors and does not require the 
direct phosphorylation of ERK1/2 by PKD1 [52]. Aldosterone can also stimulate 
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the prolonged activation of ERK1/2 in CCD cells as this process is coupled to 
Ki-RasA expression where aldosterone can also stimulate Ki-RasA GTPase activity 
within 15 min of treatment [53]. Another non-genomic kinase signaling target of 
aldosterone is the p38 MAPK subfamily. The biphasic activation of p38 in vascular 
smooth muscle cells (VSMC) can occur within 1 min of aldosterone treatment 
[54], which is followed by a second activation phase measurable after 30 min. 
The p38 response in VSMC is dependent on the co-activation of MR and c-Src and 
links p38 to the pro-fibrotic effects of aldosterone on VSMC via the regulation of 
NADPH. Furthermore, MR-dependent activation of p38 in glomerular podocytes 
from rats is also promoted by aldosterone, and this p38 activation contributes to the 
induction of apoptosis [55].
PKC isoforms have diverse roles and regulate critical cellular processes such as 
proliferation and trafficking. The PKC family of kinases are well-established targets 
of rapid aldosterone non-genomic responses [2, 4, 43]. For example, aldosterone 
can promote the activation of PKCα in renal collecting duct cells within 2–5 min 
after treatment. This activation appears to occur in an MR-independent manner 
[56, 57] and involves aldosterone binding directly to the kinase [58] along with a 
simultaneous rise in intracellular Ca2+. Additionally, PKCδ and PKCε can also be 
rapidly activated in response to aldosterone; however, this does not involve the 
direct binding of the hormone to the kinase but is coupled to MR through EGFR 
transactivation [12]. The protein kinase D isoform PKD1 activation by aldosterone 
follows a similar pattern and has been implicated in the induction of proliferation in 
M1-CCD cells following aldosterone treatment [59] as well as in the stimulation of 
hypertrophy in cardiac myocytes [60].
Figure 2. 
Aldosterone-induced protein kinase signaling and their modulation of membrane ion transporters in renal 
CCD. Fundamental signaling intermediates such as protein kinase A (PKA), protein kinase C (PKC), protein 
kinase D (PKD), phosphoinositide 3-kinase (PI3K), serum- and glucocorticoid-activated kinase (SGK), Rho-
activated kinase (ROK), the with no lysine family kinases (WNKs), and the extracellular stimulus-regulated 
kinase (ERK) are rapidly phosphorylated following treatment with aldosterone. Once activated, these signaling 
intermediates modulate the activity of ENaC, ROMK, ATP-sensitive K+ channels (KATP), Na
+/H+ exchanger-1 
(NHE1), and the Na/K pump (Na+/K+-ATPase) in the principal cells of the collecting duct. Aldosterone 
induces rapid stimulation of H+-ATPase pumps in the A-type intercalated cells via PKC-dependent trafficking 
of the proton pump into the apical membrane. Large-conductance K+ (BK) channel activity is modulated 
by aldosterone and is involved in the shift of kidney anion exchanger (kAE) activity from the basolateral 
membrane to the apical membrane (modified from [4]).
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Aldosterone can also upregulate serum glucocorticoid kinases; although this 
activation can be rapid within 20 min, it does not appear to be a non-genomic 
response but rather dependent on genomic expression of the kinase. ENaC activity 
is regulated by the aldosterone-targeted kinase serum glucocorticoid kinases which 
is present in all eukaryotes and exits in multiple isoforms, for example, SGK1, 
SGK2, and SGK3. All isoforms have been shown to promote ENaC activity with 
SGK1 and SGK3 being the most potent stimulators of this activity when they have 
been co-expressed in Xenopus oocytes [61, 62]. Aldosterone and other glucocor-
ticoid hormones induce the transcription of SGK1 by acting via nuclear receptors 
that bind to the response elements in the SGK1 gene. The subsequent rapid increase 
in SGK1 at both the protein and mRNA level stimulated ENaC-mediated Na+ cur-
rents in the epithelium of several tissues such as the kidney, lung, colon, and ocular 
epithelial cells [5, 63–65]. A rapid increase in ENaC activity by elevation in the 
channel density at the membrane has been linked to the rapid vesicle trafficking 
that is coupled to the activation of the RhoA small GTPase [66].
Aldosterone can also promote the activation of second messenger responses such 
as mobilization of intracellular Ca2+, the biosynthesis of cAMP, and the release of 
nitric oxide. There are many studies documenting the rapid non-genomic rise in 
intracellular Cai
2+ in response to aldosterone including in CCD cells [67], vascular 
smooth muscle [68], colonic crypts [42], and the brain [69]. The mechanism by 
which Ca2+ influx occurs in both the colon and the renal nephron has not been fully 
described; however, Ca2+ entry into CCD cells was not sensitive to spironolactone, 
and Ca2+ entry into colonic crypt cells was PKC-dependent via L-type voltage gated 
channels [70].
The rapid transient activation of cAMP-PKA signaling by aldosterone has been 
shown in CCD cells, and the phosphorylation of CREB following aldosterone treat-
ment was found to be PKA-dependent [71]. Some research groups have reported 
aldosterone inducing the activation of PKA; however, they also describe an inhibi-
tory effect between the physiological response stimulated by the cAMP activator 
forskolin and that stimulated by aldosterone. There is also evidence suggesting that 
suppressing CREB-dependent transcription occurs via the upregulation of protein 
phosphatase 2β (PP2β) activation by aldosterone [72]. This could be due in part to 
the separate activation of isoforms of adenylate cyclase and PKA by forskolin and 
aldosterone which could result in subcellular compartmentalized signaling. These 
observations point to a negative feedback loop that is intrinsic to aldosterone signal-
ing thus making cells more refractive to further PKA stimulation after the initial 
aldosterone-induced response.
1.3 Transduction of non-genomic aldosterone responses through the MR
As MR is at present the only widely recognized receptor that is specific to 
aldosterone, considerable effort has been put in to understand how nuclear recep-
tors such as MR can initiate rapid non-genomic protein kinase signaling cascades, 
in particular in concert with the transactivation of membrane-associated receptors 
EGFR and GPER [13, 17, 73]. A number of strands of evidence point to MR as being 
the receptor responsible for initiating the aldosterone-induced non-genomic rapid 
signaling cascades in the CCD [74]. The activation of protein kinases such as PKD 
and ERK1/2 by aldosterone can be inhibited with the use of MR-specific antago-
nists such as spironolactone and eplerenone [12, 74]. Moreover, rapid actions of 
aldosterone in MR-null cells can be conferred through exogenous expression of the 
receptor in Chinese hamster ovarian (CHO) and human embryonic kidney (HEK) 
cells [74]. MR can be considered to be a multifunctional receptor. If recombinant 
MR, which lacks its DNA-binding and coactivator-binding domains, is expressed, 
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signaling events can be instigated by a rapid response to aldosterone independent 
of transcriptional activity [75]. In terms of the intermediate phases that couple the 
aldosterone-MR interaction with the rapid activation of protein kinases, there are 
still some questions to be addressed.
Aldosterone/MR can activate non-genomic signaling pathways which regulate 
renal sodium transport and cell proliferation via transactivation of the membrane-
bound epidermal growth factor receptor EGFR [12, 59, 76–79]. Several groups 
have shown a rapid (<5 min) increase in the phosphorylation of EGFR following 
the treatment with aldosterone which induces ERK1/2 activation and an increase 
in intracellular Ca2+ [12, 81]. A major signaling pathway that is known to mediate 
MR transactivation of EGFR is the cytosolic tyrosine kinase c-Src pathway [81, 
82]. When c-Src is activated, it phosphorylates EGFR to activate ERK1/2 signaling, 
and when c-Src is inhibited, the rapid effect of aldosterone is completely abolished 
indicating that aldosterone transactivation of EGRF and MAPK pathways occurs 
via c-Src. Phosphorylated ERK1/2 can provoke several cellular responses that range 
from the activation of Na+/H+ exchange to cell proliferation [83, 84]. The transac-
tivation of EGFR is not unique to aldosterone and is typically an intermediate step 
in the transduction of rapid non-genomic membrane-initiated signaling responses 
stimulated by other steroid hormones such as estrogen [85] and G-protein-coupled 
receptor agonists [86, 87]. Although it is now well established that the transactiva-
tion of EGFR is a fundamental step in linking the initiation of the non-genomic 
aldosterone/MR signal to aldosterone-responsive downstream kinase signaling 
intermediates, it has yet to be determined by which molecular mechanism EGFR 
and its activation are coupled to MR, but it is thought to be ligand-independent EGF. 
EGFR is phosphorylated by c-Src, within 5 min of treatment with aldosterone, and 
c-Src phosphorylation could be a significant transducing signal [82]. Cytoplasmic 
Aldo/MR is recruited into a complex of several proteins including heat shock protein 
90 (Hsp90); this complex dissociates on MR activation allowing c-Src phosphoryla-
tion of EGFR. The aldosterone-induced phosphorylation of EGFR by c-Src can 
be blocked by antagonizing Hsp90 interactions with other proteins using the 
geldanamycin analogue 17-AAG. Inhibiting Hsp90 also suppresses EGFR-dependent 
downstream signaling events initiated by aldosterone which include the activation 
of protein kinase D1 [12] and the ERK1/2 mitogen-activated protein (MAP) kinase 
[25]. The ErbB family of receptor tyrosine kinases (including its member EGFR) can 
also be activated independently of ligand binding via phosphorylation of specific 
residues that are distinct from autophosphorylation sites. For example, EGFR can be 
phosphorylated at Tyr845 by Src tyrosine kinases which result in the activation of 
EGFR without requiring binding of the receptor to EGF [78, 80, 88].
Other receptors have been implicated in transducing the non-genomic aldo-
sterone actions on protein kinases including stimulation at the membrane that 
could be initiated via GPCRs, tyrosine kinases, or an as yet “unknown” membrane-
associated aldosterone receptor [89]. There is also evidence for direct activation of 
specific protein kinases by steroid hormones such as vitamin D binding to catalytic 
domains on the kinase [90], and this appears to be also relevant for aldosterone 
activation of PKCα [91]. Aldosterone can bind directly to the C2 domain of PKCα, 
with a binding affinity of between 0.5 and 1 nM, which results in the autophos-
phorylation of PKCα [58]. There have also been numerous reports proposing 
GPER (GPR30), a G-protein-coupled estrogen receptor, as a novel non-genomic 
aldosterone receptor [17, 92, 93]. Some rapid responses to aldosterone in smooth 
muscle have been linked to GPER-coupled signaling pathway in which the expres-
sion of GPER is required for the MR-independent rapid effects of aldosterone [94]. 
However, the specificity of GPER to bind selectively to steroid hormone ligands 
remains controversial [95].
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2. Protein kinase D signaling
Protein kinase D (PKD) is a serine/threonine kinase that includes three iso-
forms: PKD1/PKCμ, PKD2, and PKD3/PKCν [96]. PKD isoforms contain a tandem 
repeat of zinc finger-like cysteine-rich motifs at the N-terminus that exhibit a 
strong affinity for diacylglycerol (DAG) or phorbol ester as well as a pleckstrin 
homology domain and a C-terminal catalytic domain that has a similar homology 
with calmodulin-dependent kinases. While the PKD family contain a homologous 
catalytic domain, each isoform varies with respect to their subcellular localization, 
expression, and regulation. PKD isoforms are DAG and PKC effectors that facilitate 
the actions of growth factors, hormones, and other stimuli that can activate phos-
pholipase C (PLC). PKDs have a pair of C1 domains that bind to DAG and phorbol 
esters. Membrane-associated DAG can bind to and subsequently activate PKD and 
in turn recruit PKD via its C1 domains. PKC phosphorylates Ser744 and Ser748 in 
the activation loop of PKD. DAG-stimulated PKCs (δ, ε, θ, and η) have been shown 
to be PKD dominant activators. However, Ca+- and DAG-activated PKCs α, βi, and 
βii have also been demonstrated to activate PKD.
PKD isoforms are known to modulate the relative activity of both the ERK and 
JNK pathways whereby they can attenuate the c-Jun phosphorylation and JNK 
activation in response to the activation of EGFR while stimulating the ERK and Ras 
pathways. The PKD family of kinases can regulate budding of secretory vesicles 
from the trans-Golgi network, and this process is required for locomotion and 
localization and activity of the Rac1-dependent leading edge in fibroblasts. In addi-
tion to a major regulatory role in cell trafficking and motility, PKD also stimulates 
the recruitment of integrin to newly formed focal adhesions as well as the invasion 
of cancer cells. Moreover, PKD has been shown to have a role in the regulation of 
apoptosis, the differentiation of T cells in transgenic models, and reintroduction 
of DNA synthesis that can be induced by phorbol esters and regulatory peptides 
that act through Gq-coupled receptors and cardiac hypertrophy [97]. PKD has 
been implicated as a facilitator of stress and multiple disease states, for example, 
human hypertrophic cardiomyopathy, the activation of NFκB which is induced by 
Bcr-Abl in human myeloid leukemia and in oxidative stress responses. PKD isoform 
involvement in facilitating a wide array of both normal and abnormal biological 
actions in different subcellular compartments is most likely to be dependent on 
dynamic alterations in the isoform spatial and temporal localization in combination 
with their substrate specificity. This is particularly relevant for understanding the 
physiological role of non-genomic aldosterone activation of PKD in the regulation 
of renal Na+ transport [2, 4].
Previous studies have shown the PKD isoforms undergo rapid subcellular redis-
tribution in response to cellular stimulation. For example, PKD can be phosphory-
lated and activated by novel PKC isoforms PKCε and PKCη. We have demonstrated 
that the aldosterone activation of PKD1 in CCD cells is PKCε dependent [7, 12].
Both PKD1 and PKD2 are known to translocate from the cytosol to DAG-
containing microenvironments in the plasma membrane which is followed by 
PKC-dependent reverse translocation from the membrane to the cytosol where they 
subsequently accumulate in the nucleus [98]. In contrast to the first two isoforms, 
PKD3 constantly shuttles between the cytoplasm and the nucleus [99]. The PKD 
family members can pool and localize at the Golgi complex and the mitochondria. 
Additionally, PKD1 and PKD2 contain short PDZ-binding motifs in their COOH 
termini, namely, VSIL in PKD1 and ISVL in PKD2, which can form complexes with 
regulatory factors in multiple subcellular locations, thereby controlling various cellular 
activities. The PKD family of kinases are potent regulators of many biological pro-
cesses such as cell proliferation, polarity, migration, differentiation, reorganization of 
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the actin cytoskeleton, membrane trafficking, vesicle fission, gene expression, inflam-
mation, and hypertrophy [97]. PKD isoforms are also important players in several 
pathologies associated with both the cardiovascular and renal systems. For example, 
PKD1 has been implicated in cardiac hypertrophy, while PKD1 and PKD2 activations 
have been associated with the proliferation of endothelial cells and angiogenesis.
2.1 Regulation of cell polarity and trafficking by PKD
The establishment and the maintenance of cell polarity are essential for the 
functions of several cell types including epithelial cells. In polarized epithelial cells, 
PKD1 and PKD2 regulate the production of TGN carriers that are intended to locate 
to the basolateral membrane which suggests that PKD isoforms may have a key role 
in the generation of epithelial polarity [100].
PKD has been implicated in the many facets of the regulation of subcellular 
trafficking either by maintenance of the structure in the Golgi or by the regula-
tion of fission at the trans-Golgi network (TGN) [101, 102]. PKD can also regulate 
Golgi to membrane vesicle trafficking by activating phosphatidylinositol (PtdIns) 
4-kinase (PI4KIIIβ) and phosphatidylinositol 4-phosphate 5-kinase (PI4P5K). PKD1 
phosphorylates PI4KIIIβ at the Golgi which in turn promotes vesicle fission and 
subsequently the rate of protein transport to the plasma membrane.
Activated PKD1 phosphorylates and activates phosphatidylinositol 4-kinase IIIb 
(PI4KIIIb) at the cis- and trans-Golgi promoting the synthesis of phosphatidylino-
sitol-4-phosphate (PI4P) in the Golgi membrane. Ceramide transport protein is 
released from the endoplasmic reticulum and binds to PI4P, so transporting lipid 
from the ER to the Golgi. Ceramide is processed at the Golgi to produce sphingo-
myelin and diacylglycerol. DAG recruits PKD1 and novel PKC isoforms as well as 
multiple proteins recruited to sites of PI4P biogenesis in the Golgi. These include 
the arfaptin family proteins. These proteins contain a BAR (Bin/Amphiphysin/Rvs) 
domain with a concave anionic surface that interacts with negatively charged lipid 
membranes to facilitate vesicle fission. Other known substrates for PKD1 include 
actin cytoskeleton regulatory proteins such as cofilin, LIM kinase (LIMK), and 
rhotekin that contribute to actin-dependent intracellular vesicle trafficking.
2.2 Non-genomic aldosterone signaling through protein kinase D pathways
Aldosterone/MR signaling via PKD signaling pathways has been shown to be a 
key regulator of the transduction of non-genomic responses to the hormone [2, 4]. In 
renal CCD cells, PKD1 acts as a potent regulator of ENaC and Na+/K+-ATPase traf-
ficking and activity under basal and aldosterone-stimulated conditions [102]. The 
activation of PKD1 at the trans-Golgi network (TGN) by aldosterone is an important 
regulatory mechanism of ENaC trafficking. Aldosterone rapidly (<5 min) induces 
the interaction between PKD1 and PI4KIIIβ which regulates the signaling of protein 
kinases and the lipid modification that is essential for vesicle fission. The rapid 
phosphorylation activation of PKD1 by aldosterone primes the CCD cells for subse-
quent transcriptional events which increase the expression of ENaC channel subunit 
proteins. Vital roles of other PKD isoforms including PKD2 and PKD3 in the CCD are 
emerging with the identification of novel substrates for this kinase family that include 
other kinases and transcription factors responsible for modulating gene expression 
and intracellular trafficking. All three PKD isoforms are highly expressed in renal 
CCD cells and were found to be localized to principal cells in mouse and rat CCD using 
AQP1 co-localization immunofluorescence assays (Figure 3). Rats fed a low Na+ diet 
for 2 weeks showed increased expression of PKD1 in the CCD principal cells. Confocal 
immunohistochemistry microscopy revealed the basal expression of PKD1 to be 
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mainly in the trans-Golgi network and cytosolic compartment; PKD2 was localized 
almost exclusively at the apical membrane, whereas PKD3 was mainly localized in the 
cytosol and nucleus (Figure 3).
The different PKD isoforms exhibit distinct differences in terms of their subcel-
lular localization, which is also influenced by cell type [103]. We have established 
that PKD1 is expressed throughout the cytosol of principal cells in the renal CCD 
cells with accumulation in the trans-Golgi network proximal to the nucleus (266). 
This structure was identified as the TGN with the use of a specific marker, TGN38. 
PI4KIIIβ is phosphorylated by PKD1 at the TGN with subsequent upregulation 
in vesicle fission, and we found that PI4KIIIβ was also localized to the TGN in 
M1-CCD cells [8]. The TGN association of PI4KIIIβ was not affected by the suppres-
sion of PKD1 expression. Treatment with aldosterone did not affect the distribution 
of PKD1 or PI4KIIIβ at the TGN but did promote the formation of an immuno-
precipitatable complex between these two kinases within 5 min. This complex 
remained stable for at least 30 min, consistent with the sustained autophosphoryla-
tion of PKD1 detectable following treatment with aldosterone [7]. The interaction 
between these two kinases was also observed following the long-term aldosterone 
stimulation ranging between 1 and 24 h.
2.3 Integration of aldosterone genomic and non-genomic actions through PKD 
signaling pathways
Recent work has focused on the physiological role of non-genomic actions of 
aldosterone, its consequences for genomic responses, and the integration or cross 
Figure 3. 
Subcellular distribution of PKD isoforms in rat renal CCD cells. The PKD isoforms are stained with isoform-specific 
fluorescence antibodies in green, the nucleus with DAPI stain in blue, and the plasma membrane with actin in red. 
Following aldosterone treatment, PKD1 rapidly (10 min) localized to apical and basolateral plasma membranes, 
PKD2 moved out of the apical membrane into the cytosol, and PKD3 became concentrated in the nucleus.
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talk between rapid and latent hormone responses for regulating renal Na+ reabsorp-
tion [2, 4, 104, 105].
The activity of crucial rapid signaling intermediates such as PKD, Rho-
activated kinase (ROK), protein kinase A (PKA), phosphoinositide 3-kinase 
(PI3K), PKC, ERK, SGK, and with no lysine family kinases (WNK) can be modu-
lated by aldosterone. Aldosterone activates some or all of these signaling pathways 
to modulate ENaC channel activity along with other transporters involved in 
transepithelial sodium reabsorption such as the ATP-sensitive K+ channel and 
Na+/K+ pump in principle cells of the CCD. The activation of aldosterone/MR also 
leads to a suppression of Nedd4-2 ubiquitin ligase activity via SGK which promotes 
ENaC abundance in the apical membrane [5]. Aldosterone stimulates transcrip-
tional changes in promoting SGK-1 thus inactivating Nedd4-2. This inactivation 
of Nedd4-2 leads to an increase in ENaC abundance possibly by inhibiting degra-
dation of the channel rather than by membrane insertion or stabilization of the 
channel complex.
The rapid non-genomic signaling responses induced by aldosterone affect mul-
tiple protein kinase signaling pathways, either by directly affecting their activity 
or indirectly through the modulation of MR-dependent transcription. Both PKCδ 
and PKCε can be rapidly activated in response to aldosterone; however, this is not 
reliant on the direct binding of aldosterone to the kinase. The rapid activation is 
instead coupled to MR via the transactivation of EGFR (109). The rapid activation 
of PKD1 in response to aldosterone is now known to be a substrate for novel, Ca2+-
independent PKC isoforms (nPKCs), for example, PKCδ and PKCε. In renal CCD 
cells, aldosterone stimulates PKD1 activation in the same manner as aldosterone-
induced activation of nPKC isoforms. The rapid activation of PKD1 is coupled to 
MR through the transactivation of EGFR [12].
Aldosterone (rapidly <5 min) activates (phosphorylation) PKD1 in CCD cells 
through MR transactivation of the EGF receptor involving downstream PKCδ and 
PKCε and ERK signaling. Aldosterone activation of PKD1 caused translocation of 
ENaC and Na/K-ATPase pump subunits from the trans-Golgi network to apical and 
basolateral membrane domains, respectively, within 15 min, via the PKD1-PI4KIIIβ 
trafficking signaling pathway. Knockdown of PKD1 resulted in a 50% reduction 
in the basal transepithelial Na+ transport rate concomitant with mislocalization 
of ENaC to basolateral membranes and Na/K pumps to apical membranes. PKD1 
knockdown prevented the genomic response of aldosterone-stimulated transepithe-
lial Na+ reabsorption as measured by the amiloride-sensitive short-circuit current 
(SCC) in Ussing chambers [8].
Protein kinase D2 is also rapidly activated by aldosterone to modulate ENaC 
membrane abundance and stability. CCD epithelia in which PKD2 was knocked 
down showed an increased localization and stabilization of ENaC in apical mem-
branes and an increased basal SCC of fivefold above control levels in wild-type CCD 
after 24 h. Paradoxically, aldosterone treatment inhibited SCC by 40% after 24 h 
in PKD2 null M1 cells. However, the SCC levels following aldosterone treatment 
in PKD2 null CCD epithelia were still 30% higher than the SCC levels observed in 
aldosterone-treated wild-type CCD. In addition, PKD2 knockdown has revealed a 
novel inhibitory pathway for aldosterone regulation of ENaC activity which may 
have a physiological function to “brake” over-stimulation of renal Na reabsorption 
in the CCD [109].
The protein kinase D3 isoform appears not to mediate non-genomic aldosterone 
responses. Knockdown of PKD3 in CCD cells did not affect the non-genomic 
responses to aldosterone on ENaC trafficking but reduced the genomic response to 
the hormone to increase the expression of ENaC alpha subunits and SGK [109].
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PKD isoforms are a major critical and essential signal transduction pathway for 
the transduction of both non-genomic and genomic aldosterone/MR regulation 
of Na+ transport in the CCD. PKD signaling integrates non-genomic and genomic 
responses to aldosterone through PKD1-stimulated ENaC and Na/K pump traffick-
ing, PKD2-dependent ENaC membrane stabilization, and PKD3-stimulated ENaC 
subunit expression (Figure 4).
2.4 Mechanisms of PKD activation by aldosterone
PKD isoforms are downstream targets for active PKCs and can be activated by 
agonists of G-protein-coupled receptors. Aldosterone induces both rapid phosphor-
ylation and activation of PKD1 [12]. It has been shown that aldosterone activation 
of PKD1 in CCD cells is PKCε-dependent via aldosterone/MR transactivation of the 
EGF receptor. The molecular mechanisms of aldosterone activation/phosphoryla-
tion of PKD2 and PKD3 isoforms are currently unknown.
2.5 The mineralocorticoid receptor is a non-genomic receptor for aldosterone 
PKD signaling
A number of strands of evidence point to MR as being the receptor responsible for 
initiating the aldosterone-induced rapid activation of PKD signaling cascades. The 
activation of protein kinases such as PKD and ERK1/2 by aldosterone, for example, 
can be inhibited with the use of MR-specific antagonists such as spironolactone and 
eplerenone. MR can be considered to be a multifunctional receptor. If recombinant 
MR which lacks its DNA-binding and coactivator-binding domains is expressed, 
signaling events can be instigated by a rapid response to aldosterone independent of 
transcriptional activity. The aldosterone/MR-induced phosphorylation of PKD1 via 
EGFR transactivation by c-Src can be blocked by antagonizing Hsp90 interactions 
using the geldanamycin analogue 17-AAG. This suppresses EGFR-dependent down-
stream PKD1 signaling events initiated by aldosterone that include the activation of 
ENaC trafficking and the ERK1/2 mitogen-activated protein (MAP) kinase [7, 8].
Figure 4. 
PKD isoforms regulate ENaC and Na/K pump activity by both non-genomic and genomic aldosterone/MR 
signaling in the CCD. PKD signaling integrates non-genomic and genomic responses to aldosterone through 
non-genomic PKD1-stimulated ENaC and Na/K pump trafficking from the trans-Golgi network to apical 
and basolateral membranes, respectively, and PKD2-dependent ENaC membrane stabilization, and genomic 
PKD3-stimulated ENaC subunit expression.
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3. Aldosterone regulation of ENaC activity via PKD signaling pathways
Our research group has published a series of papers describing the molecular 
mechanisms of PKD1 modulation of ENaC Na+ channel trafficking and function 
by aldosterone [2, 4]. Non-genomic aldosterone signaling mainly regulates ENaC 
activity by stimulating ENaC trafficking from the cytosol to the apical membrane 
and by enhancing membrane abundance and membrane stability of functional 
channels. Aldosterone treatment rapidly stimulates the apical translocation of 
ENaCα, ENaCβ, and ENaCγ subunits in wild-type M1-CCD via PKD1 signaling, 
but in PKD1 knockdown cells, aldosterone treatment fails to increase ENaC subunit 
abundance at the apical membrane which remains localized in the cytoplasm. Thus 
the trafficking process of ENaCα, ENaCβ, and ENaCγ to the apical membrane is 
defective in CCD cells suppressed in PKD1 expression and indicates a critical role 
of this protein kinase in regulating subcellular trafficking of ENaC subunits by 
aldosterone. The rapid effects of aldosterone on ENaC subcellular redistribution 
precede the genomic increase in the Na+ transport rate through ENaC in CCD cells 
which is normally detected between 2 and 4 h following treatment with aldosterone 
and peaks between 16 and 24 h. We have previously reported that the formation 
of membrane-bound structures that were found to be rich in ENaC subunits was 
observed following aldosterone stimulation for 5 min. It has been proposed that an 
ER-Golgi intermediate compartment could be the initial site for the post-ER sorting 
of proteins. This is consistent with the subcellular redistribution of ENaC chan-
nel subunits observed within 2 min of aldosterone stimulation. Previous studies 
on ENaC-related acid-sensing ion channel (ASIC) suggested that a functional 
heterodimeric ENaC assembles in the endoplasmic reticulum prior to it undergo-
ing posttranslational modifications as it passes through the Golgi. ENaC is found 
in vesicles throughout the cytoplasm of cells under high Na+ where its depletion or 
exposure to aldosterone results in the subsequent translocation of ENaC to the api-
cal membrane without undergoing transcriptional changes [106]. The rapid surface 
translocation of ENaC and its increased activity has been reported in response to 
agonists; for example, a twofold increase in the amiloride-sensitive short-circuit 
current (SCC, transepithelial Na+ current) was observed after 25 min of treatment 
with forskolin in CCD cells [107]. This increase in SCC coincided with an increase in 
the apical membrane expression of ENaC. Aldosterone/MR controls the transcrip-
tion of ENaCα in renal cells, while the remaining subunits, ENaCβ and ENaCγ, are 
expressed constitutively. We have previously shown that the long-term treatment 
with aldosterone increases the localization of ENaCα and ENaCβ at the apical 
membrane in M1-CCD cells which is dependent on PKD1 expression and activation 
[7]. Further studies showed that aldosterone induces the rapid translocation of 
ENaCβ and ENaCγ to the plasma membrane within 30 min of treatment and that 
this translocation, in common with PKD1 activation, was MR-dependent [8].
Aldosterone also induces a rapid phosphorylation (activation) and redistribution 
of PKD2 from the apical membrane into the cytosol of CCD cells. Genetic suppres-
sion of PKD2 in renal CCD cells results in an increase in the abundance of ENaCγ 
at the apical membrane under both basal and aldosterone-treated conditions. The 
abundant expression of ENaC at the apical membrane is associated with very high 
basal Na+ currents through ENaC in PKD2 knockdown CCD epithelia and reveals 
a tonic inhibition of ENaC function by PKD2 under basal conditions [109]. In its 
inactive state, PKD2 stimulates the retrieval of the ENaCγ channel subunits out of the 
apical membrane back into the cytosol thus de-stabilizing ENaC membrane expres-
sion and activity. Aldosterone treatment removes this tonic endocytosis of ENaC by 
phosphorylating PKD2 causing the kinase to be removed from the membrane and 
inhibiting the retrieval of ENaCγ into the cytosol. In contrast, when PKD2 expression 
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was suppressed by siRNA, the tonic retrieval of ENaC from the apical membrane 
was removed and ENaC expression was stabilized and enhanced at the membrane 
resulting in very large basal ENaC-mediated Na+ currents. Moreover, a paradoxical 
inhibitory effect of aldosterone on ENaC Na+ currents was observed in PKD2 knock-
down CCD cells. Given that ENaC activity is a balance between membrane expression 
and retrieval, the overall regulation of transepithelial sodium transport under basal 
and aldosterone-stimulated conditions is under the influence of the relative effects of 
PKD1, PKD2, and SGK1 on ENaC stability in the membrane (Figure 5).
3.1 Molecular mechanisms of ENaC trafficking regulated by PKD1
Membrane-localized ENaC is subject to constant recycling. The inclusion of ENaC 
into the apical membrane is a prerequisite for its ubiquitination and retrieval into the 
subapical pool or its degradation by the proteasome. Nedd4-2 interacts with ENaC 
through a C-terminal PY internalization motif to facilitate ENaC ubiquitination. The 
surface expression of ENaC may be equally regulated by deubiquitination by DUBs 
and ubiquitination by Nedd4-2. However, only PKD1 and PKD2 isoforms provide 
the composite signaling pathway for the basal control and acute stimulatory effect of 
aldosterone that influences cellular trafficking dynamics controlling ENaC and Na/K 
pump membrane targeting, insertion, stabilization, and retrieval (Figure 6).
Figure 5. 
Effects of PKD1 and PKD2 knockdown on basal and aldosterone-regulated ENaC activity. In wild-type CCD 
cells, aldosterone induces an increase in the ENaC-dependent transepithelial sodium transport measured by 
the amiloride-sensitive short-circuit current (Isc) in M1-CCD epithelia mounted in Ussing chambers. Isc is 
stimulated following aldosterone phosphorylation and activation of PKD1 and SGK1 which together stimulate 
and stabilize the trafficking of ENaC into the apical membrane. Aldosterone also phosphorylates PKD2 which 
decreases the retrieval of ENaC back into the cytosol and contributes to the increase in Isc. When PKD1 is 
suppressed (PKD1 KD), ENaC membrane insertion is decreased, and both basal and aldosterone Isc responses 
are suppressed. Knocking down PKD2 (PKD2 KD) in CCD cells has an inhibitory effect on the retrieval of 
ENaC from the apical membrane thus enhancing the stability of the channel resulting in an elevated basal Isc. 
Paradoxically, hormone stimulation in PKD2 knockdown CCD inhibits Isc and produces a blunted Isc response 
compared to aldosterone-treated wild-type CCD. Thus PKD2 KD unmasks an inhibitory aldosterone signaling 
pathway which reduces functional ENaC activity.
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3.2 Molecular mechanisms of ENaC trafficking regulated by PKD2
The rapid non-genomic activation of PKD1 by aldosterone has been dem-
onstrated in renal CCD and the implications this has on renal Na+ absorption in 
terms of trafficking and activity of transporters such as ENaC and Na+/K+-ATPase 
pump. To date, less is known about the role of PKD2 in regulating basal ENaC and 
Na/K pump activity and aldosterone-stimulated renal Na+ reabsorption. There is 
evidence from transcriptomics studies that the Pkd2 gene is expressed in the mouse 
distal convoluted tubule and the collecting duct but not in the connecting tubule 
[108]. PKD2 protein expression had not been described in the kidney before, and 
recent studies have shown the expression of PKD2 in mouse and rat distal renal 
tubules ex vivo and in M1-CCD cells in vitro [109]. The PKD2 isoform was found 
to be ubiquitously expressed along the length of the distal tubule with the highest 
expression in the distal convoluted tubule and the connecting tubule and lower 
levels of expression along the collecting duct. PKD2 was expressed primarily in the 
principle cells and to a lesser extent in the intercalated cells. The distribution of 
PKD2 was also determined in rats fed a normal Na+ diet and a diet poor in Na+ in 
order to elevate plasma levels of aldosterone so as to determine if high aldosterone 
states can cause shifts in the cellular distribution of PKD2 in the distal nephron. 
Under basal conditions, the PKD2 cellular distribution appeared mainly local-
ized at the apical membrane (co-localized with AQP2) and showed the lowest 
expression in the cytosol and was excluded from the nucleus. A similar subcellular 
distribution of PKD2 was observed in confluent M1-CCD monolayers which also 
exhibited high PKD2 expression at the plasma membrane and low expression in the 
cytosol. In high aldosterone states, PKD2 translocates from the apical membrane 
to a cytosolic compartment. Thus PKD2 shows the opposite pattern of subcellular 
expression compared to PKD1 under both basal and aldosterone-stimulated condi-
tions. The mechanism by which aldosterone produces a redistribution of PKD2 
from the plasma membrane may involve PKC which is also rapidly activated by 
aldosterone in CCD.
Figure 6. 
ENaC and Na/K pump membrane targeting under the control of PKD1. PKD1 regulates the correct targeting 
of ENaC and Na+/K+-ATPase to the apical and basolateral membranes, respectively. Knocking down PKD1 
expression in CCD cells results in the defective membrane sorting of ENaC and Na/K pump such that their 
membrane expression polarity is inverted.
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The question arises if PKD2 has a role in regulating the subcellular expres-
sion and trafficking of ENaC channel subunits as has been observed for PKD1 in 
CCD. In other renal tissues, PKD2 has also been shown to function in the basolateral 
transport of proteins, and knocking down PKD2 affects the membrane trafficking 
of E-cadherin and β1-integrin [100]. In polarized MDCK cells, the transient expres-
sion of a PKD2 kinase-dead mutant resulted in the co-accumulation of E-cadherin, 
β1-integrin, and the PKD2 mutant at the TGN. It has also been suggested that PKD2 
is unlike the other two PKD isoforms because the activation of PKD2 was not shown 
to induce its redistribution to the nucleus from the cytoplasm. It has also been 
shown that the activation of NFκB by PKD2 occurs in response to oxidative stress 
and is not dependent on its catalytic activity. This suggests that PKD2 could have a 
distinctive regulatory property in comparison to PKD1 and PKD3.
The role of PKD2 in early rapid signaling responses to aldosterone stimulation in 
Na+ transport has become clearer. Previous work has shown that PKD1 is activated 
in M1-CCD cells within 5 min in response to aldosterone. A similar activation kinet-
ics has been observed for PKD2 in M1-CCD cells where aldosterone stimulated the 
autophosphorylation of PKD2 within 10 min coupled with translocation of PKD2 
from the cell membrane to the cytosol [109]. Moreover, under low Na+ diet and high 
aldosterone states, a similar shift in the cellular distribution of PKD2 occurs in the 
rat distal nephron.
Recent studies have revealed a novel role for PKD2 in the trafficking of ENaC 
channel subunits [109]. Under basal conditions, ENaCγ is mainly localized in 
the cytosol. Upon stimulation with aldosterone, ENaCγ is trafficked to the apical 
membrane, but this response was absent in M1-CCD cells where PKD2 expression 
was knocked down using siRNA. The genetic silencing of PKD2 in M1-CCD cells 
produced a higher basal expression of ENaCγ in the apical membrane and a cor-
responding stimulation of Na+ transport through ENaC. Paradoxically, aldosterone 
treatment produced a redistribution of ENaCγ out of the apical membrane into the 
cytosol and a suppressed Isc response in M1-CCD cells deficient in PKD2 (Figure 5).
Genetic knockdown of PKD2 in M1-CCD cells results in a stimulation of transepi-
thelial Na+ transport under basal conditions. This increase in ENaC activity cor-
responds with an increase in basal expression of ENaCγ in PKD2 knockdown CCD 
when compared to wild-type cells. An inhibition of PKD2-dependent endocytotic 
retrieval of ENaC channel subunits into the cytosol may result in an increase in both 
the total ENaC abundance in the membrane and the increase in channel activity. 
Another possibility for the increase in transepithelial sodium transport in PKD2 
knockdown cells could result from an increase in the PKD1-dependent trafficking of 
ENaC channel subunits. There is also a possibility that PKD1 activity could increase 
in order to compensate for the absence of PKD2 by upregulating PI4KIIIβ trafficking 
and therefore affecting ENaC membrane insertion. Unexpectedly, aldosterone treat-
ment stimulated a retrieval of ENaCγ from the apical membrane into the cytoplasm 
in PKD2-deficient CCD cells. The inhibition of transepithelial Na+ transport by 
aldosterone in PKD2 knockdown CCD presents a paradox for the classical activation 
of ENaC by the hormone in wild-type CCD. One would presume that aldosterone 
could continue to stimulate ENaC activity in the absence of PKD2 in this model due 
to an upregulation of PKD1- and SGK-dependent ENaC trafficking and membrane 
stabilization. However, from these findings, we propose that PKD1 and PKD2 exert 
opposite effects on ENaC membrane abundance and that aldosterone, by activat-
ing PKD2 and removing it from the membrane, releases a tonic inhibition of ENaC 
stability exerted by unphosphorylated PKD2. The translocation and targeting of 
ENaC and Na/K pump to the apical membrane and basolateral membranes and their 
membrane stabilization are dependent on cooperative PKD1 and PKD2 non-genomic 
signaling that may potentiate or synergize with the latent genomic aldosterone 
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effects on ENaC protein expression and membrane abundance. PKD1 is a crucial 
regulator of the apical membrane-directed trafficking of ENaC. Furthermore, it was 
shown that PKD1 regulates the membrane localization of the Na+/K+-ATPase pump, 
and knocking down PKD1 resulted in the mislocalization of the pump β subunit 
to the apical membrane and bulk accumulation of the pump protein in the cytosol 
rather than in the basolateral membranes [8]. Similarly, aldosterone stimulation of 
PKD1 knockdown M1-CCD cells failed to increase the basolateral membrane abun-
dance of the Na+/K+ pump normally seen in wild-type cells (Figure 7).
3.3 PKD1, PKD2, SGK1, and the regulation of ENaC membrane trafficking and 
stability
The upregulation of SGK1 is the earliest transcriptional and translational 
response that is elicited by aldosterone, whereas PKD1 and PKD2 are the earliest 
activated kinases in the non-genomic response to aldosterone in the regulation 
of ENaC trafficking and stabilization in the apical membrane stabilization. The 
interactions between aldosterone-stimulated PKD1, PKD2, and SGK have not been 
investigated; however, certain predictions to guide future research can be proposed 
and tested (Figure 8). Given that PKD1, PKD2, and SGK would be expected to 
enhance ENaC trafficking, insertion, and stability and to reduce ENaC retrieval 
and degradation following aldosterone treatment, it would be expected that some 
cross talk and coordination would exist between these kinases in their kinetics of 
activation, subcellular localization, and cooperativity. However, from previous 
Figure 7. 
PKD isoforms exert opposite effects on the membrane abundance and localization of ENaC and Na/K pump 
with consequences for Na+ transport. The PKD1 isoform regulates the insertion of ENaC channel subunits into 
the apical membrane of CCD cells. Aldosterone activates the PKD1-dependent trafficking of ENaC subunits 
to the membrane. In contrast, PKD2 exerts a tonic inhibitory effect on ENaC by stimulating the retrieval of 
ENaC from the apical membrane into the cytosol under basal conditions. Stimulating PKD2 with aldosterone 
results in the inhibition of ENaC retrieval back into the cytosol and an increased abundance of ENaC at 
the apical membrane along with an increase in ENaC activity. Genetic knockdown of PKD1 inhibits ENaC 
trafficking into the apical membrane under both basal and aldosterone conditions, whereas knockdown of 
PKD2 releases the tonic inhibition of ENaC activity and suppresses its retrieval by the kinase resulting in a 
higher abundance and membrane stability of ENaC with consequent elevated Na+ reabsorption (IENaC and 
Ipump). Aldosterone produces a paradoxical inhibition of ENaC membrane abundance and depresses Na
+ 
reabsorption in PKD2 knockdown CCD.
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work it appears that SGK does not play an essential role in basal or Na+ deprivation-
induced renal Na+ transport or ENaC activity, whereas PKD1 and PKD2 expression 
and activation are absolutely critical for the maintenance of basal and aldosterone-
stimulated ENaC function and transepithelial sodium transport.
3.4 PKD3 regulation of ENaC and renal Na+ transport
To date, the role of PKD3 in the kidney remains unknown. PKD3 is unlike the 
other two isoforms whereby it is present in the nucleus as well as the cytoplasm in 
unstimulated cells. Currently, investigations of PKD3-dependent signaling path-
ways in the kidney are lacking, while studies in other tissues and cell types have 
been reliant on the use of non-specific pharmacological inhibitors or the use of 
small interfering RNA (siRNA). We have used both siRNA and CRISPR/Cas knock-
down of PKD3 in M1-CCD cells to obtain some insights into a potential role for 
PKD3 in the renal transport of sodium. Preliminary data show that PKD3 is primar-
ily localized in the cytoplasm and perinuclear region and translocates to the nucleus 
under aldosterone treatment or low Na+ diet  [109].
PKD3 knockdown resulted in reduced genomic expression of the ENaCα 
subunit and SGK. Long-term treatment with aldosterone (24–48 h) produced a 
reduced sodium transport rate in PKD3 suppressed cells compared to wild-type 
CCD. Knockdown of PKD3 did not interfere with PKD1 nor PKD 2 non-genomic 
signaling in response to aldosterone nor did it significantly affect basal Na+ transport 
rates. It thus appears that PKD3 is a genomic signal pathway for aldosterone regula-
tion of ENaC and SGK and may synergize and reinforce with the non-genomic PKD1 
and PKD2 modulation of ENaC trafficking and membrane stabilization (Figure 9).
Figure 8. 
ENaC membrane insertion, stability, and removal are under the control of interactions between PKD1, 
PKD2, and SGK1. Aldosterone activates PKD1 to stimulate the insertion of ENaC into the apical membrane. 
The PKD1-dependent insertion of ENaC increases endocytosis of preformed ENaC subunits into the apical 
membrane. Additionally, SGK1 is phosphorylated to prevent the ubiquitination of ENaC. In the basal 
unphosphorylated state, PKD2 tonically stimulates the retrieval of ENaC from the apical membrane. When 
PKD2 is phosphorylated by aldosterone, the activated PKD2 may increase deubiquitination thus stabilizing 
ENaC in the membrane. Genetic silencing of PKD2 results in the stabilization of ENaC in the apical 
membrane which may be due to a decrease in the activity of deubiquitinases. Knocking down SGK1 in CCD 
cells stimulates the retrieval of ENaC from the membrane while suppressing PKD1 results in the inhibition of 
ENaC insertion in response to aldosterone.
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4. Conclusions and perspectives
The physiological and pathophysiological roles of PKD isoforms in different 
biological systems are becoming better understood with the identification of 
novel substrates for this family of kinases that also interact with other kinases and 
transcription factors which modulate intracellular trafficking, membrane targeting, 
and stability of ion transport proteins. These PKD isoform-regulated biological 
processes fine-tune the aldosterone/MR-dependent transcriptional events and 
act as important intermediaries between rapid non-genomic signaling and latent 
transcriptional responses activated by aldosterone to regulate renal electrolyte 
homeostasis. The development of PKD isoform-specific knockdown or knockout 
renal CCD cell lines and animal models has the potential to reveal novel rapid non-
genomic and genomic roles for PKD isoforms to regulate basal and aldosterone-
stimulated ENaC and Na+/K+-ATPase pump activity in renal CCD cells.
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Figure 9. 
Regulation of ENaC and Na/K pump by protein kinase D isoforms. PKCδ and PKCε can be rapidly activated in 
response to aldosterone. The rapid activation of PKC is coupled to MR via the transactivation of EGFR through 
c-Src. PKD1 is the downstream of PKCδ and PKCε, and once activated, it is responsible for the trafficking of 
ENaC channel subunits from the cytosol to the apical membrane. PKD2 activation by aldosterone removes a tonic 
inhibition of ENaC membrane stability and increases the stability of ENaC channels in the membrane. PKD3 
activation exerts a stimulatory effect on the expression of ENaC channel subunits and SGK, further amplifying 
and sustaining the non-genomic response to regulate renal Na+ reabsorption and blood volume/pressure.
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